We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
+3.44%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$103B
AUM Growth
-$8.16B
(-7.4%)
Cap. Flow
-$11.8B
Cap. Flow
% of AUM
-11.46%
Top 10 Holdings %
Top 10 Hldgs %
16.83%
Holding
4,113
New
322
Increased
874
Reduced
2,317
Closed
300
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AABA
Altaba Inc
AABA
|
+$587M |
| 2 |
UBS Group
UBS
|
+$204M |
| 3 |
iShares MSCI Brazil ETF
EWZ
|
+$177M |
| 4 |
iShares MSCI South Korea ETF
EWY
|
+$159M |
| 5 |
HES
Hess
HES
|
+$141M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
US Bancorp
USB
|
+$559M |
| 2 |
VanEck Gold Miners ETF
GDX
|
+$479M |
| 3 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$329M |
| 4 |
YHOO
Yahoo Inc
YHOO
|
+$316M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$281M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 11.17% |
| 2 | Technology | 10.29% |
| 3 | Healthcare | 9.29% |
| 4 | Consumer Staples | 6.63% |
| 5 | Consumer Discretionary | 6.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SCMP
3476
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
| $143K | ﹤0.01% |
13,649
-51,856
| -79% | -$529K |
|
|
AGRX
3477
DELISTED
Agile Therapeutics
AGRX
| $142K | ﹤0.01% |
+19
| New | +$132K |
|
|
EVRI
3478
DELISTED
Everi Holdings
EVRI
| $139K | ﹤0.01% |
18,996
-1,794
| -9% | -$11.6K |
|
|
PFNX
3479
DELISTED
Pfenex Inc.
PFNX
| $139K | ﹤0.01% |
+34,721
| New | +$160K |
|
|
CRR
3480
DELISTED
Carbo Ceramics Inc.
CRR
| $139K | ﹤0.01% |
20,109
-5,899
| -23% | -$48.5K |
|
|
TLGT
3481
DELISTED
Teligent, Inc
TLGT
| $138K | ﹤0.01% |
1,514
-433
| -22% | -$36.9K |
|
|
TESO
3482
DELISTED
Tesco Corp
TESO
| $138K | ﹤0.01% |
30,862
-15,628
| -34% | -$86.2K |
|
|
MACK
3483
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $138K | ﹤0.01% |
14,159
-33,445
| -70% | -$683K |
|
3484
Cerus
CERS
$615M
| $137K | ﹤0.01% |
54,306
-21,974
| -29% | -$70.3K |
|
3485
Immersion
IMMR
$256M
| $137K | ﹤0.01% |
15,105
-2,795
| -16% | -$24.1K |
|
|
USAK
3486
DELISTED
USA Truck Inc
USAK
| $137K | ﹤0.01% |
+15,854
| New | +$109K |
|
|
SFS
3487
DELISTED
Smart & Final Stores, Inc.
SFS
| $137K | ﹤0.01% |
15,072
-31,515
| -68% | -$377K |
|
|
JMBA
3488
DELISTED
Jamba, Inc.
JMBA
| $135K | ﹤0.01% |
+17,308
| New | +$135K |
|
|
TTOO
3489
DELISTED
T2 Biosystems, Inc
TTOO
| $134K | ﹤0.01% |
+8
| New | +$160K |
|
|
LBY
3490
DELISTED
Libbey, Inc.
LBY
| $133K | ﹤0.01% |
16,538
-7,739
| -32% | -$75.2K |
|
3491
Denison Mines
DNN
$2.64B
| $132K | ﹤0.01% |
298,881
-8,869
| -3% | -$4.5K |
|
|
MRO
3492
CALL
DELISTED
Marathon Oil Corporation
MRO
| $130K | ﹤0.01% |
+11,000
| New | +$154K |
|
3493
Lipocine
LPCN
$17.6M
| $127K | ﹤0.01% |
+1,864
| New | +$122K |
|
3494
Seres Therapeutics
MCRB
$47M
| $127K | ﹤0.01% |
+563
| New | +$116K |
|
3495
Arq
ARQ
$85.4M
| $125K | ﹤0.01% |
+13,716
| New | +$129K |
|
|
SDRL
3496
DELISTED
Seadrill Limited Common Stock
SDRL
| $125K | ﹤0.01% |
1,295
-702
| -35% | -$110K |
|
|
ZOES
3497
DELISTED
Zoe's Kitchen, Inc.
ZOES
| $125K | ﹤0.01% |
10,525
-778
| -7% | -$12.5K |
|
|
NETI
3498
DELISTED
Eneti Inc.
NETI
| $121K | ﹤0.01% |
1,837
-135
| -7% | -$8.85K |
|
|
NVTA
3499
DELISTED
Invitae Corporation
NVTA
| $118K | ﹤0.01% |
12,347
-12,831
| -51% | -$127K |
|
3500
LifeVantage
LFVN
$80.4M
| $114K | ﹤0.01% |
+26,203
| New | +$116K |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q2 2017 Portfolio in Review
As of Q2 2017, Credit Suisse held 4,113 positions worth $103B, down 7.4% from $111B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Credit Suisse withdrew a net $11.8B in Q2 2017, closing 300 positions and reducing 2,317 holdings. Its most notable exit was Yahoo Inc, an estimated $316M position sold in full.
By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 11% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Credit Suisse opened a new position in Altaba Inc worth $587M.
- Credit Suisse's largest Q2 2017 buy was Altaba Inc: 10,781,590 shares worth $587M.
- Credit Suisse added most to UBS Group in Q2 2017, an estimated $204M increase.
- Credit Suisse's biggest Q2 2017 reduction was US Bancorp, cutting an estimated $559M.
- Credit Suisse fully exited Yahoo Inc in Q2 2017, selling an estimated $316M.
- Credit Suisse's ten largest holdings make up 17% of its $103B portfolio in Q2 2017.
- Credit Suisse opened 322 new positions and closed 300 in Q2 2017.
- Credit Suisse's portfolio value fell 7.4% quarter-over-quarter to $103B.
Based on Credit Suisse's 13F filing for Q2 2017, filed 14 Aug 2017.